Development

Nucleus promotes embryo-selection IQ estimates

The newsletter contrasts promotional estimates with the figures and qualifications in company materials.

development2026-09-20biotech

Claim

The newsletter reports Nucleus's claim of a 14-point IQ benefit from embryo selection and contrasts it with a whitepaper figure of ±10.8 across five embryos; these are claims rather than verified outcomes.

Reported metric: 14 IQ points; ±10.8; five embryos

Reporting date: (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Indexed from the September 20 newsletter. Linked-source claims have not been independently verified.

Knowledge graphopen in browser →

Reported in
Actor
Referenced by

Cite or correct this record

Suggest a correction — opens a GitHub draft for you to review and submit.